Status:
COMPLETED
Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)
Lead Sponsor:
Queen Mary University of London
Conditions:
Tobacco Dependence
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Varenicline and nicotine replacement therapy (NRT) are both effective smoking cessation treatments. Anecdotally smokers who are finding their quit attempt difficult have reported benefiting from addin...
Eligibility Criteria
Inclusion
- Smokers seeking treatment
- Aged 18 and over
- Consenting to take part in the trial
Exclusion
- Pregnant or breastfeeding
- End-stage renal disease
- Unable to fill in questionnaires in English
- Previous allergy to Varenicline
- Previous allergy to Nicotine Patches Previous allergy to varenicline
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT01184664
Start Date
April 1 2011
End Date
October 1 2011
Last Update
October 11 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tobacco Dependence Research and Treatment Unit
London, United Kingdom, E1 2JH
2
Tobacco Dependence Research Unit
London, United Kingdom, E1 2JH